Founders Capital Management (Texas)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.5K Hold
1,200
0.03% 125
2025
Q1
$73.2K Hold
1,200
0.05% 100
2024
Q4
$67.9K Hold
1,200
0.04% 114
2024
Q3
$62.1K Hold
1,200
0.04% 125
2024
Q2
$49.8K Hold
1,200
0.03% 140
2024
Q1
$65.1K Buy
1,200
+100
+9% +$5.42K 0.04% 118
2023
Q4
$56.4K Buy
1,100
+100
+10% +$5.13K 0.04% 128
2023
Q3
$58K Hold
1,000
0.04% 122
2023
Q2
$64K Hold
1,000
0.05% 125
2023
Q1
$69K Hold
1,000
0.05% 115
2022
Q4
$72K Hold
1,000
0.05% 105
2022
Q3
$71K Hold
1,000
0.06% 103
2022
Q2
$77K Buy
1,000
+1
+0.1% +$77 0.06% 100
2022
Q1
$62K Hold
999
0.04% 111
2021
Q4
$62K Buy
999
+100
+11% +$6.21K 0.04% 111
2021
Q3
$53K Buy
899
+400
+80% +$23.6K 0.04% 117
2021
Q2
$33K Hold
499
0.02% 150
2021
Q1
$32K Hold
499
0.02% 138
2020
Q4
$31K Buy
+499
New +$31K 0.02% 145
2020
Q1
$28K Hold
499
0.03% 126
2019
Q4
$32K Hold
499
0.02% 142
2019
Q3
$25K Sell
499
-701
-58% -$35.1K 0.02% 161
2019
Q2
$54K Hold
1,200
0.05% 107
2019
Q1
$57K Hold
1,200
0.05% 102
2018
Q4
$62K Hold
1,200
0.07% 92
2018
Q3
$74K Hold
1,200
0.06% 94
2018
Q2
$66K Sell
1,200
-41,159
-97% -$2.26M 0.06% 104
2018
Q1
$2.68M Hold
42,359
2.26% 12
2017
Q4
$2.6M Hold
42,359
2.15% 15
2017
Q3
$2.7M Sell
42,359
-28
-0.1% -$1.79K 2.24% 12
2017
Q2
$2.36M Buy
42,387
+3,395
+9% +$189K 2.09% 16
2017
Q1
$2.12M Buy
+38,992
New +$2.12M 1.91% 18